Expert Video - How do doctors treat lung cancer with HER2 mutations?
Medical oncologist Dr. Naomi Fujioka of the University of Minnesota provides an overview of how doctors treat HER2-mutated lung cancer. She discusses trastuzumab deruxtecan, which is an antibody-drug conjugate, and discusses some of the side effects of treatment. She also talks about clinical trials to develop new treatments for HER2-mutated lung cancer.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
Other Modules:
Animation - Understanding NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
Slide Show - Understanding NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
1.
What is a gene mutation and how does it relate to lung cancer?
2.
How do doctors test for genetic mutations in lung cancer and why is it important?
3.
What is an ALK rearrangement in lung cancer?
4.
How do doctors treat ALK-rearranged lung cancer?
5.
What is a BRAF mutation in lung cancer?
6.
How do doctors treat lung cancer with BRAF mutations?
7.
What is a ROS1 mutation in lung cancer?
8.
How do doctors treat lung cancer with ROS1 mutations?
9.
What is a HER2 mutation in lung cancer?
10.
How do doctors treat lung cancer with HER2 mutations?
11.
What is a MET mutation in non-small cell lung cancer (NSCLC)?
12.
How do doctors treat lung cancer with MET mutations?
